{"id":131485,"date":"2024-08-20T15:00:09","date_gmt":"2024-08-20T09:30:09","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=131485"},"modified":"2024-08-21T08:15:16","modified_gmt":"2024-08-21T02:45:16","slug":"smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/","title":{"rendered":"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-4233525475\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Pharma Stock which is India&#8217;s leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3897453945\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading\"><strong>Price Action&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 4,070 Crores, the shares of <strong>Sequent Scientific Limited<\/strong> were trading at Rs. 163 per equity share, up 4 percent from its previous day\u2019s close price of Rs. 157.35. It has delivered a return of 84 percent in a year.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened&nbsp;<\/strong><\/h2><p>Sequent Scientific Limited has received prequalification (PQ) approval from the World Health Organization (WHO) for Albendazole, Active Pharmaceutical Ingredient (API). This was developed in partnership with Mepro Pharmaceuticals Private Limited, who have successfully developed and commercialized the Albendazole Chewable formulation from its WHO prequalification-approved plant, using its API.&nbsp;<\/p><p>Albendazole is a vital medication used to treat a range of parasitic infections, including tapeworm, roundworm, and hookworm infestations, affecting millions globally, particularly in low and middle-income countries.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-733504790\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The WHO prequalification recognizes Sequent Scientific Limited&#8217;s commitment to stringent international standards in the production of Albendazole API, ensuring efficacy, safety, and quality&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Management Message&nbsp;<\/strong><\/h2><p>Rajaram Narayanan, MD &amp; CEO of Sequent Scientific Limited said \u201cThe WHO prequalification approval validates our manufacturing capabilities and reinforces our dedication to providing high-quality, affordable medicines to those in need worldwide. By leveraging our extensive distribution network and strategic partnerships, the company is poised to make a meaningful impact on health outcomes on a global scale,\u201d&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Sequent Scientific Limited is India&#8217;s leading animal health company, with a presence in 5+ continents across 100 countries. It provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials and Ratios&nbsp;<\/strong><\/h2><p>Its Revenue from operations grew by 17.11 percent from Rs. 333.21 Crores in Q1FY24 to Rs. 390.21 Crores in Q1FY25, accompanied by a loss of Rs. 34.68 Crores to Rs. 9.06 Crores.&nbsp;<\/p><p>In terms of Return ratios, it has reported a return on equity (ROE) of -2.46 percent, and a return on capital employed (ROCE) of 0.90 percent. It has reported a debt-to-equity ratio of 0.74.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by: Bharath K.S<\/strong><\/p>\n\n<h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4>\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div>\n\n<p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><\/blockquote><div class=\"trade-after-content\" id=\"trade-1401805575\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Pharma Stock which is India&#8217;s leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.&nbsp; Price Action&nbsp; With a market capitalization of Rs. 4,070 Crores, the shares [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":131486,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31,13525],"tags":[],"class_list":["post-131485","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news","category-stock-updates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Pharma Stock which is India&#039;s leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0\" \/>\n<meta property=\"og:description\" content=\"Pharma Stock which is India&#039;s leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-20T09:30:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-21T02:45:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/\",\"url\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/\",\"name\":\"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg\",\"datePublished\":\"2024-08-20T09:30:09+00:00\",\"dateModified\":\"2024-08-21T02:45:16+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Pharma Stock which is India's leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0 - Trade Brains Features","description":"Pharma Stock which is India's leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/","og_locale":"en_US","og_type":"article","og_title":"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0","og_description":"Pharma Stock which is India's leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-08-20T09:30:09+00:00","article_modified_time":"2024-08-21T02:45:16+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/","url":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/","name":"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg","datePublished":"2024-08-20T09:30:09+00:00","dateModified":"2024-08-21T02:45:16+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Pharma Stock which is India's leading animal health company, engaged in providing a wide-ranging portfolio including Finished Dose Formulations, APIs, and many more jumped 11 percent in the day\u2019s trade upon receiving prequalification (PQ) approval for its API from the World Health Organization.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/08\/WHO.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-11-after-it-receives-who-approval-for-its-albendazole-api\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Smallcap stock jumps 11% after it receives WHO approval for its Albendazole API\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=131485"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131485\/revisions"}],"predecessor-version":[{"id":131487,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/131485\/revisions\/131487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/131486"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=131485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=131485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=131485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}